COVID-19 Update: India records 26 new coronavirus cases, infection tally stands at 4.49 crore

COVID-19 Update: India has recorded 26 new coronavirus infections, while the active cases have been recorded at 520, according to the Union Health Ministry data. 

COVID-19 Update: India records 26 new coronavirus cases, infection tally stands at 4.49 crore
The death toll has been recorded at 5,32,030, the data updated at 8 am stated. Pic: IANS

COVID-19 Update: India has recorded 26 new coronavirus infections, while the active cases have been recorded at 520, according to the Union Health Ministry data updated on Tuesday. The death toll has been recorded at 5,32,030, the data updated at 8 am stated.

The country's Covid case tally is 4.49 crore (4,49,98,243).

The number of people who have recuperated from the disease has increased to 4,44,65,693 and the national recovery rate stands at 98.81 per cent, according to the health ministry's website.

Also Read: Nipah: What do we know about virus spreading in India's Kerala?

The case fatality rate stands at 1.18 per cent.

According to the ministry's website, 220.67 crore doses of Covid vaccine have been administered in the country so far.

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

RECOMMENDED STORIES

https://www.zeebiz.com/personal-finance/photo-gallery-power-of-compounding-interest-mutual-fund-sip-retirement-corpus-planning-calculator-how-many-years-it-will-take-to-reach-inr-rs-30000000-with-4000-5000-and-6000-monthly-investment-market-linked-return-324325

Power of Compounding: How many years will it take to reach Rs 3 crore corpus if your monthly SIP is Rs 4,000, Rs 5,000, or Rs 6,000

https://www.zeebiz.com/personal-finance/news-sip-mutual-fund-power-of-compounding-retirement-corpus-planning-calculator-salary-inr-rs-25000-per-month-is-it-possible-to-create-over-26367030-fund-calculations-324366

Power of Compounding: Salary Rs 25,000 per month; is it possible to create over Rs 2.60 crore corpus; understand it through calculations

https://www.zeebiz.com/personal-finance/news-reduce-home-loan-emi-or-reduce-tenure-rs-75-lakh-25-year-home-loan-which-option-can-save-rs-25-lakh-and-64-months-and-how-know-here-324393

Reduce Home Loan EMI vs Reduce Tenure: Rs 75 lakh, 25-year loan; which option can save Rs 25 lakh and 64 months and how? Know here

https://www.zeebiz.com/personal-finance/photo-gallery-top-7-large-and-mid-cap-sip-mutual-funds-with-highest-best-xirr-returns-in-5-years-no-1-scheme-has-turned-rs-inr-15000-monthly-investment-into-rs-2054384-uti-icici-hdfc-bank-hsbc-quant-motilal-324344

Top 7 Large and Mid Cap Mutual Funds with Best SIP Returns in 5 Years: No. 1 fund has turned Rs 15,000 monthly SIP investment into Rs 20,54,384; know about others

https://www.zeebiz.com/markets/stocks/photo-gallery-stock-to-buy-for-long-term-on-new-year-samvat-2081-by-anil-singhvi-iifl-finance-share-price-target-nse-bse-smallcap-stock-324310

New Year Pick by Anil Singhvi: This smallcap stock can offer up to 75% return in long term - Check targets

https://www.zeebiz.com/markets/stocks/photo-gallery-share-price-target-of-indian-oil-bharat-petroleum-hindustan-petroleum-largecap-psu-stocks-324329

PSU Oil Stocks: Here's what brokerage suggests on these 2 largecap, 1 midcap scrips - Buy, Sell or Hold?

https://www.zeebiz.com/personal-finance/photo-gallery-sbi-pnb-hdfc-bank-3-year-senior-citizen-fd-fixed-deposit-interest-rate-maturity-return-calculator-which-bank-gives-highest-on-inr-rs-500000-investment-state-bank-of-india-punjab-national-guaranteed-return-scheme-324094

Senior Citizen FD: SBI 3-year FD vs PNB 3-year FD vs HDFC Bank 3-year FD; which FD will give highest return on Rs 5 lakh investment

Written By: PTI
Updated: Tue, Sep 19, 2023
02:21 PM IST
PTI
RELATED NEWS
Yatra ordered to refund booking amount to COVID lockdown-affected consumers Yatra ordered to refund booking amount to COVID lockdown-affected consumers
'Single-minded focus on safety first, followed by efficacy': Bharat Biotech highlights 5 key milestones of COVAXIN 'Single-minded focus on safety first, followed by efficacy': Bharat Biotech highlights 5 key milestones of COVAXIN

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x